GE HealthCare Technologies Management

Management criteria checks 0/4

GE HealthCare Technologies' CEO is Pete Arduini, appointed in Dec 2022, has a tenure of 1.42 years. total yearly compensation is $24.51M, comprised of 5.1% salary and 94.9% bonuses, including company stock and options. directly owns 0.001% of the company’s shares, worth MX$7.86M. The average tenure of the management team and the board of directors is 1.3 years and 1.3 years respectively.

Key information

Pete Arduini

Chief executive officer

US$24.5m

Total compensation

CEO salary percentage	5.1%
CEO tenure	1.4yrs
CEO ownership	0.001%
Management average tenure	1.3yrs
Board average tenure	1.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Pete Arduini's remuneration changed compared to GE HealthCare Technologies's earnings?
Date	Total Compensation	Salary	Company Earnings
Mar 31 2024	n/a	n/a	US$2b
Dec 31 2023	US$25m	US$1m	US$1b
Sep 30 2023	n/a	n/a	US$2b
Jun 30 2023	n/a	n/a	US$2b
Mar 31 2023	n/a	n/a	US$2b
Dec 31 2022	US$10m	US$1m	US$2b

Compensation vs Market: Pete's total compensation ($USD24.51M) is above average for companies of similar size in the MX market ($USD5.98M).

Compensation vs Earnings: Pete's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Pete Arduini (58 yo)

1.4yrs

Tenure

US$24,510,947

Compensation

Mr. Peter J. Arduini, also known as Pete, serves as Director of Ge Healthcare since January 2023. He was a Senior Vice President at General Electric Company since January 2022. He has been President and Ch...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Peter Arduini	President	1.4yrs	US$24.51m	0.0013% $ 7.9m
James Saccaro	VP & CFO	less than a year	US$10.97m	no data
Taha Kass-Hout	Chief Science & Technology Officer	1.3yrs	US$13.87m	0.0037% $ 23.2m
Frank Jimenez	VP, General Counsel & Corporate Secretary	1.3yrs	US$7.51m	0.0042% $ 26.5m
Jan Makela	President & CEO of Imaging	no data	US$5.85m	0.0064% $ 39.9m
George Newcomb	Controller & Chief Accounting Officer	1.4yrs	no data	0.0012% $ 7.2m
Jahid Khandaker	Chief Information Officer	no data	no data	no data
Carolynne Borders	Chief Investor Relations Officer	no data	no data	no data
Rana Strellis	Chief Corporate Marketing & Communications Officer	no data	no data	no data
Thomas Westrick	President & CEO of Patient Care Solutions	4.3yrs	no data	0.0020% $ 12.2m
Kevin O'Neill	President & CEO of Pharmaceutical Diagnostics	no data	no data	0.0016% $ 10.1m
Roland Rott	President & CEO of Ultrasound	1.3yrs	no data	0.0029% $ 18.2m

1.3yrs

Average Tenure

54yo

Average Age

Experienced Management: GEHC *'s management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

Name	Position	Tenure	Compensation	Ownership
Peter Arduini	President	1.3yrs	US$24.51m	0.0013% $ 7.9m
H. Culp	Chairman	1.3yrs	US$531.65k	0.024% $ 148.7m
Risa Lavizzo-Mourey	Lead Independent Director	1.3yrs	US$456.65k	0.00023% $ 1.4m
Anne Madden	Independent Director	1.3yrs	US$401.61k	0% $ 0
William Stromberg	Independent Director	1.3yrs	US$421.58k	0% $ 0
Rodney Hochman	Independent Director	1.3yrs	US$401.61k	0% $ 0
Lloyd Howell	Independent Director	1.3yrs	US$401.65k	0% $ 0
Tomislav Mihaljevic	Independent Director	1.3yrs	US$401.65k	0% $ 0
Phoebe Yang	Independent Director	1.3yrs	US$401.65k	0% $ 0
Catherine Lesjak	Independent Director	1.4yrs	US$426.65k	0% $ 0

1.3yrs

Average Tenure

59.5yo

Average Age

Experienced Board: GEHC *'s board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.

GE HealthCare Technologies Management

Management criteria checks 0/4

Key information

Recent management updates

Insider recently bought Mex$1.7m worth of stock

High number of new and inexperienced directors

GE HealthCare Technologies Inc., Annual General Meeting, May 21, 2024

GE Healthcare Technologies Inc. Announces Resignation of Betty D. Larson as Chief People Officer

High number of new and inexperienced directors

High number of new and inexperienced directors

Recent updates

GE HealthCare Unveils SIGNA MAGNUS, an FDA 510(K) Pending Head-Only Magnetic Resonance (MR) Scanner Designed to Explore Advance Advancements in Neuro Science

Insider recently bought Mex$1.7m worth of stock

GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress

First quarter 2024 earnings released: EPS: US$0.82 (vs US$0.41 in 1Q 2023)

GE HealthCare Technologies Inc. Reaffirms Earnings Guidance for the Full Year 2024

High number of new and inexperienced directors

GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women's Health Imaging

GE HealthCare Technologies Inc. to Report Q1, 2024 Results on Apr 30, 2024

GE HealthCare Technologies Inc., Annual General Meeting, May 21, 2024

GE Healthcare Introduces Caption AI on Vscan Air SL Wireless Handheld Ultrasound System to Help More Clinicians Capture Diagnostic-Quality Cardiac Images

GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist

GE HealthCare Technologies Inc. to Feature Latest Technologies in Interventional Radiology Focused on Precision Care At Sir 2024

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

GE HealthCare Technologies Inc. has completed a Follow-on Equity Offering in the amount of $1.06925 billion.

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

Full year 2023 earnings released

GE Healthcare Technologies Inc. Announces Resignation of Betty D. Larson as Chief People Officer

GE HealthCare Technologies Inc. Receives 510(K) Clearance from the United States Food and Drug Administration for Novii™+ Wireless Patch Solution

High number of new and inexperienced directors

GE HealthCare Technologies Inc. Announces Prucka 3 Digital Amplifier as Next Generation Platform for Electrophysiology Innovation

GE HealthCare Technologies Inc. to Report Q4, 2023 Results on Feb 06, 2024

High number of new and inexperienced directors

GE HealthCare Technologies Inc. (NasdaqGS:GEHC) entered into definitive agreement to acquire MIM Software Inc.

GE HealthCare Highlights Commitment to Delivering Better Patient Experiences and Outcomes Through Deep Learning at RSNA 2023

GE HealthCare Expands On-Device Triage Capabilities of Critical Care Suite with FDA Clearance of Algorithm for Pneumothorax Detection, Notification, Triage and Diagnosis

GE HealthCare Technologies Inc. Releases MyBreastAI Suite to Support Clinicians in Accelerating Breast Cancer Detection

High number of new and inexperienced directors

GE Healthcare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies

GE HealthCare Technologies Inc. Provides Earnings Guidance for the Year 2023

Third quarter 2023 earnings released

GE HealthCare Technologies Inc. Announces to Showcase Some of the Latest Innovations Designed to Help Clinicians in the Treatment of Cardiovascular Disease At the 2023 Transcatheter Cardiovascular Therapeutics Conference

GE HealthCare Technologies Inc. to Report Q3, 2023 Results on Oct 31, 2023

GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence

GE HealthCare Announces Study Results Demonstrating Portrait Mobile Continuous Monitoring Solution Performance with Patients and Care Teams in the Ward

GE HealthCare Launches Enhanced Venue Family Ultrasound Systems Featuring AI-Driven Caption Guidance

GE HealthCare Technologies Inc. Announces Cash Dividend for Third Quarter of 2023, Payable on November 15, 2023

GE HealthCare Introduces Vscan Air SL, Wireless Handheld Ultrasound Device for Rapid Assessments of Cardiac and Vascular Patients

High number of new and inexperienced directors

GE HealthCare Technologies Inc. Receives FDA Clearance for Portrait Mobile, Wireless Monitoring Solution Aiding Early Detection of Patient Deterioration

CEO of Pharmaceutical Diagnostics recently sold Mex$3.0m worth of stock

Second quarter 2023 earnings released: EPS: US$0.92 (vs US$1.04 in 2Q 2022)

GE HealthCare Technologies Inc. Provides Earnings Guidance for the Full Year 2023

Upcoming dividend of US$0.03 per share at 0.1% yield

GE HealthCare Technologies Inc. to Report Q2, 2023 Results on Jul 25, 2023

GE HealthCare Technologies Inc. Announces Cash Dividend for Second Quarter of Fiscal Year 2023, Payable on August 15, 2023

GE HealthCare Technologies Inc. Announces the First Patient Scanned in a Phase I Clinical Trial of a Fluorine-18 PET Radiopharmaceutical

CEO of Ultrasound recently sold Mex$3.3m worth of stock

GE HealthCare Technologies Inc. has completed a Follow-on Equity Offering in the amount of $1.95 billion.

GE HealthCare Technologies Inc. has completed a Follow-on Equity Offering in the amount of $1.95 billion.

GE HealthCare Releases Reimagining Better Health

GE HealthCare Introduces Sonic DL

GE HealthCare Technologies Inc. Receives FDA Clearance of a New Deep Learning Solution for Enhanced Image Quality in PET/CT, Advancing its Leadership Position in AI

GE HealthCare Technologies Inc. Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)

High number of new and inexperienced directors

GE HealthCare Introduces Innovations to Improve Radiation Therapy Efficiency and Precision Care at the European Society for Therapeutic Radiology and Oncology 2023 Congress

GE Healthcare Technologies Inc. Announces Chief Financial Officer Changes, Effective from June 1, 2023

CEO of Imaging recently sold Mex$8.3m worth of stock

GE HealthCare Technologies Inc. (NasdaqGS : GEHC) signed an agreement to acquire Caption Health, Inc.

Full year 2022 earnings released

GE Healthcare Technologies Inc. Reaffirms Earnings Guidance for the Full Year 2023

Investor sentiment improves as stock rises 16%

GE Healthcare Technologies Inc. Reports Preliminary Revenue Results for the Fourth Quarter and Full Year 2022

GE HealthCare Technologies Inc. to Report Q4, 2022 Results on Jan 30, 2023

No independent directors

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team